CAPN5
Basic information
Region (hg38): 11:77066961-77126155
Previous symbols: [ "VRNI" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant neovascular inflammatory vitreoretinopathy (Moderate), mode of inheritance: AD
- autosomal dominant neovascular inflammatory vitreoretinopathy (Supportive), mode of inheritance: AD
- CAPN5-related vitreoretinopathy (Definitive), mode of inheritance: AD
- CAPN5-related vitreoretinopathy (Strong), mode of inheritance: AD
- CAPN5-related vitreoretinopathy (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Vitreoretinopathy, neovascular inflammatory | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 23055945 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (620 variants)
- Inborn_genetic_diseases (116 variants)
- not_specified (40 variants)
- CAPN5-related_disorder (24 variants)
- Retinal_dystrophy (15 variants)
- Proliferative_vitreoretinopathy (7 variants)
- Autosomal_dominant_neovascular_inflammatory_vitreoretinopathy (5 variants)
- High_myopia (1 variants)
- Severe_early-childhood-onset_retinal_dystrophy (1 variants)
- Occult_macular_dystrophy (1 variants)
- Late-onset_cone-rod_dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAPN5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004055.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 137 | 15 | 159 | |||
| missense | 314 | 27 | 351 | |||
| nonsense | 14 | 14 | ||||
| start loss | 0 | |||||
| frameshift | 16 | 17 | ||||
| splice donor/acceptor (+/-2bp) | 5 | |||||
| Total | 4 | 0 | 356 | 165 | 21 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CAPN5 | protein_coding | protein_coding | ENST00000278559 | 12 | 59223 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.52e-8 | 0.995 | 125624 | 0 | 124 | 125748 | 0.000493 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.534 | 394 | 425 | 0.927 | 0.0000295 | 4179 |
| Missense in Polyphen | 158 | 188.81 | 0.83684 | 1866 | ||
| Synonymous | 0.0735 | 177 | 178 | 0.993 | 0.0000129 | 1250 |
| Loss of Function | 2.56 | 18 | 34.1 | 0.527 | 0.00000190 | 345 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00118 | 0.00117 |
| Ashkenazi Jewish | 0.00129 | 0.00129 |
| East Asian | 0.000763 | 0.000761 |
| Finnish | 0.0000464 | 0.0000462 |
| European (Non-Finnish) | 0.000541 | 0.000536 |
| Middle Eastern | 0.000763 | 0.000761 |
| South Asian | 0.000263 | 0.000261 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium-regulated non-lysosomal thiol-protease. {ECO:0000250}.;
- Disease
- DISEASE: Vitreoretinopathy, neovascular inflammatory (VRNI) [MIM:193235]: An autoimmune condition of the eye that sequentially mimics uveitis, retinitis pigmentosa, and proliferative diabetic retinopathy as it progresses to complete blindness. Patients present during the second or third decade of life with posterior uveitis and reduction of the electroretinogram b-wave. They become more symptomatic when cataracts, cystoid macular edema, and disk edema diminish visual acuity during the second stage. Severe vision loss begins during the third stage when proliferative retinal neovascularization and epiretinal membranes appear. There is an ongoing pigmentary retinal degeneration and peripheral visual field loss during all stages. In the fourth stage, proliferative vitreoretinopathy causes tractional retinal detachments at the macula and vitreous base. The fifth or end- stage disease is marked by phthisis. {ECO:0000269|PubMed:23055945}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Integrin-mediated Cell Adhesion;Extracellular matrix organization;Degradation of the extracellular matrix
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.214
- rvis_EVS
- -0.9
- rvis_percentile_EVS
- 10.14
Haploinsufficiency Scores
- pHI
- 0.238
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.467
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.392
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Capn5
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- proteolysis;signal transduction
- Cellular component
- cytoplasm;focal adhesion;cell surface;extracellular exosome
- Molecular function
- calcium-dependent cysteine-type endopeptidase activity